Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review

Nazar Majeed, Zeyad; Philip, Koshy; Alabsi, A. M.; Pushparajan, Saravanan; Swaminathan, Dasan

doi:https://doi.org/10.1155/2016/1804727

Disease Markers

On this page

Abstract Introduction Results Discussion Limitations Conclusion Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2016 | Article ID 1804727 | https://doi.org/10.1155/2016/1804727

Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review

Zeyad Nazar Majeed,^1,2Koshy Philip ,³A. M. Alabsi,⁴Saravanan Pushparajan,¹and Dasan Swaminathan¹

Academic Editor: Shih-Ping Hsu

Received06 Aug 2016

Revised07 Oct 2016

Accepted23 Oct 2016

Published15 Dec 2016

Abstract

Background. Several studies in the last decades have focused on finding a precise method for the diagnosis of periodontal disease in its early stages. Aim. To evaluate from current scientific literature the most common and precise method for gingival crevicular fluid (GCF) sample collection, biomarker analytical methods, and the variability of biomarker quantification, even when using the same analytical technique. Methodology. An electronic search was conducted on in vivo studies that presented clinical data on techniques used for GCF collection and biomarker analysis. Results. The results showed that 71.1%, 24.7%, and 4.1% of the studies used absorption, microcapillary, and washing techniques, respectively, in their gingival crevicular fluid collection. 73.1% of the researchers analyzed their samples by using enzyme-linked immunosorbent assay (ELISA). 22.6%, 19.5%, and 18.5% of the researchers included interleukin-1 beta (IL-1β), matrix metalloproteinase-8 (MMP-8), and tumor necrosis factor-alpha (TNF-α), respectively, in their studies as biomarkers for periodontal disease. Conclusion. IL-1β can be considered among the most common biomarkers that give precise results and can be used as an indicator of periodontal disease progression. Furthermore, paper strips are the most convenient and accurate method for gingival crevicular fluid collection, while enzyme-linked immunosorbent assay can be considered the most conventional method for the diagnosis of biofluids.

1. Introduction

The aim of this review is to evaluate GCF sampling, analytical methods, and oral biomarkers used for the diagnosis and monitoring of different periodontal diseases. It also attempts to explore the main reasons for differences in biomarker quantification among the investigators, by reviewing studies based on inclusion and exclusion criteria from January 2005 to May 2015.

Periodontal diseases are multifactorial infections influenced by the interaction of different types of bacteria with host cells and tissues leading to the release of many cytokines and chemokines which cause the destruction of the periodontal structures [1]. GCF in subjects with periodontal disease contains inflammatory cells, bacteria, tissue breakdown products, antibodies, and complement system proteins and enzymes, in addition to many inflammatory mediators [2]. GCF can be considered among the most nontraumatic investigational methods used to provide information about periodontal tissue conditions, including the status of the connective tissue and the degree of hard tissue destruction [3]. The severity of periodontal tissue inflammation can be estimated by measuring proinflammatory indicators such as IL-1, -6, and -8 and TNF-α that have an important role in the pathogenesis of periodontal diseases [4].

Periodontal diseases must be described by a criteria that is clear and suitable for any examiner to apply, so that the same diagnosis can be reached by other examiners under same conditions [5]. The early diagnosis of periodontal diseases is of significant importance that demands a quick, sensitive, and precise chair-side analytical test [6, 7].

The methods of diagnosis should provide relevant information to assist the differentiation among a variety of periodontal diseases, the degree of periodontal tissue destruction, and the prognosis of periodontal disease. Nowadays, the basic method used in the diagnosis of periodontal diseases depends mainly on the measurement of the clinical periodontal parameters including plaque score (PS) or plaque index (PI), clinical attachment loss (CAL), probing depth (PD), gingival index (GI), or bleeding on probing (BOP), in addition to radio graphical findings. However, the findings from these clinical parameters provide evidence regarding the previous damage of the periodontium rather than clarifying the future condition of the periodontal tissue. Therefore, it is very important to find a method that can predict upcoming periodontal disease. More reliable techniques for periodontal diagnosis need to be researched [105] such as the MMP-8 chair-side testing that depends on the immunochromatography principle which could be beneficial in supporting the clinical diagnostic parameters during the maintenance phase [6, 77]. Moreover, the results from such a test increase the accuracy of the periodontal disease diagnosis and results of unsuccessful treatments [106]. However, this test is fast, inexpensive, and easily performed and takes just 5 minutes [107].

2. Methodology

2.1. Inclusion and Exclusion Criteria

Inclusion criteria in the current study included (a) clinical studies, (b) studies performed on both systemically healthy and systemically unhealthy subjects [patients with diabetes mellitus (DM), coronary heart disease, or rheumatoid arthritis (RA)] with periodontal disease, (c) studies performed on smokers, anxious, or pregnant subjects, (d) studies published only in the English language, and (e) studies clarifying the methodology for GCF sample collection and biomarkers analytical techniques. Exclusion criteria included studies specifically designed to investigate the biomarkers in peri-implant sulcus fluid (PISF), letters to the editor, historic reviews, and commentaries.

2.2. Search Protocol

PubMed, Google Scholar, and Web of Science databases from 2005 to 2015 were searched using combinations of the following keywords: “periodontal disease”, “periodontitis”, “oral biomarkers”, “biomarkers”, and “gingival crevicular fluids”. Titles and abstracts of studies were identified using the above-described protocol, selected by the authors, and checked for agreement. Full texts of the studies were determined by title and abstract and then independently assessed by the authors (Zeyad Nazar Majeed, Dasan Swaminathan, A. M. Alabsi, Koshy Philip, and Saravanan Pushparajan) with reference to the inclusion and exclusion criteria. Initially 2,765 publications were identified, while only 97 studies which fulfilled the inclusion criteria were included and processed for data extraction as shown in the flow chart (Figure 1).

3. Gingival Crevicular Fluid Collection Methods

3.1. Intracrevicular Washing Technique

The device used to perform this method consists of two injection needles placed one inside the other. This method for GCF collection was well described by Salonen and Paunio [108] and the main details of the studies that utilized washing technique in their GCF collection were briefly illustrated in Table 1.

3.2. Microcapillary Technique

A calibrated volumetric or noncalibrated microcapillary pipette with known volume is used to collect GCF. Pradeep et al. [23, 24] gave a good description in their studies on how to perform this collection technique. In this systematic review, 24 studies used this technique (Table 2).

3.3. Absorption Technique

Table 3 summarized the most important findings of the studies that used the absorption technique. Generally, this technique is divided into extracrevicular (Figure 2) and intracrevicular (Figure 3). The first one is performed by placing paper strips over the gingival crevice to reduce trauma. The second method is the intracrevicular technique which is the most commonly used. It may be subdivided into superficial and deep, depending on the depth of strip insertions into gingival sulcus or periodontal pocket [109].

4. Results

A meta-analysis of the results was not carried out in this systematic review because the heterogeneity of the reviewed studies involved the following aspects: GCF sampling, analytical methods, and oral biomarkers used in the diagnosis and monitoring of periodontal disease.

4.1. Sampling Methods

With regard to the techniques used for GCF collection, 97 studies were included and illustrated in our review (Tables 1, 2, and 3). 69 studies used paper strips for GCF collection (Table 3), 24 studies used microcapillary pipettes (Table 2), and only 4 studies utilized the gingival washing method to collect their samples (Table 1).

4.2. Analytical Methods

As shown in Tables 1, 2, and 3 many methods were employed to analyze GCF samples in order to get the desired results. The ELISA analytical method was clearly the preferred method in the majority of the studies. Seventy-one out of the 97 studies that we reviewed used the ELISA technique to analyze the GCF samples.

4.3. Biomarkers

Of the 97 studies, IL-1β (22 studies), MMP-8 (19 studies), and TNF-α (18 studies) were reviewed. These results indicated that these biomarkers concentrations could be used to compare the different stages of periodontal disease and/or assess the effectiveness of periodontal therapy.

Results on sampling and analytical methods and biomarkers are summarized in Figure 4.

4.4. IL-1β

A comparison of GCF IL-1β levels between periodontally diseased patients and healthy subjects was conducted in order to explain the suitability of using IL-1β as a biomarker for periodontal disease progression. In this comparison, only 10 studies among the 22 studies were included (Table 4), due to the exclusion of the studies that did not show enough clinical data and the studies that were conducted on periodontally diseased patients with systemic diseases (e.g., diabetes mellitus) or any other conditions that might affect the results (e.g., pregnant women and smokers). IL-1β concentrations in all studies showed moderate to high significant differences between the healthy subjects and patients with CP or GAgP.

Of the 10 studies that were included to determine the difference in IL-1β levels, only 3 studies [41, 51, 103] showed differences in IL-1β levels between healthy subjects and patients with gingivitis. However this difference was nonsignificant.

4.5. MMP-8

For MMP-8 levels differences between healthy and diseased subjects, only 4 studies fulfilled the inclusion criteria, the same as for IL-1β. All the studies (Table 5) showed differences between healthy subjects and CP patients. Although these differences were highly significant in the studies done by Konopka et al. [67], Rai et al. [88], and Teles et al. [98], it was not considered significant by Yakob et al. [11].

4.6. TNF-α

For TNF-α levels differences between healthy and diseased subjects, only 8 studies were included which fulfilled the inclusion criteria (Table 6). Reis et al. [91] showed that TNF-α levels were significantly higher in diseased sites compared to nondiseased sites. Gokul [14] showed a highly significant difference between healthy subjects and patients with gingivitis and CP. Kurtiş et al. [70] showed highly significant difference between healthy subjects and patients with CP and GAgP. However, the other studies showed only slight difference in TNF-α level between healthy and diseased subjects.

Despite the similarity in results with the majority of studies reviewed in this systematic review, there were still different effects of biomarkers on periodontal disease. The findings of the studies also determined how those biomarkers could be utilized in the diagnosis or monitoring periodontal disease status, as shown in Tables 4, 5, and 6. The present study showed that there was variability in the findings between investigators even when using the same analytical techniques. In order to clarify the differences in outcome, a comparison was made among the studies that used the same analytical methods (Tables 7 and 8).

As shown in Table 7, only five studies were included that used the same analytical method (standard ELISA technique) for quantitative determination of IL-1β concentrations. It was quite noticeable that there were differences in the values of the mean IL-1β concentrations between the studies within the same study group (H, G, CP, and GAgP). For example, the mean IL-1β concentration among healthy subjects in the five studies showed differences in mean values: 49.81, 195.77, 36.44, 15.5, and 17.8732.

Only two studies were involved for comparing MMP-8 mean values (Table 8). Both showed relatively close results in which there was a slight difference in the mean values of MMP-8 in each study group (H, CP).

5. Discussion

This systematic review was designed to discover the most common and accurate GCF collection and biomarker analytical methods and to determine the reliable biomarkers that could be used to detect periodontal disease.

5.1. GCF Sampling Methods

This paper discussed the three main methods of GCF collection: absorption, microcapillary pipetting, and the washing method. There were variations in GCF collection techniques in several of the clinical studies that were reviewed.

5.1.1. Absorption Method

The differences could be summarized as follows:(i)The majority of the studies used paper strips which were considered to be more efficient in GCF collection because they could be inserted easily into gingival sulcus or periodontal pockets, as well as for their ability to absorb fluids. However, few studies used paper points (size 30) to collect GCF samples although it was shown that paper points and paper strips had different absorption rates. A study done by Guentsch et al. [110] indicated that cytokine levels were higher when paper strips were used. Paper points are more commonly used for subgingival plaque collection in microbiological analysis.(ii)The time in which the paper strips or paper points were left in the sulcus varied between 30 seconds [68, 76, 111] and 1 minute [112]. The period most frequently used was 30 seconds to decrease the risk of blood or saliva contamination.(iii)There were variations in the sites from which the GCF samples were collected. Many studies collected GCF samples from diseased sites only [72] in patients with periodontal disease, while other researchers collected samples from both healthy and diseased sites [111].

It was thus important to note that the majority of the studies showed that biomarker levels positively correlated with the periodontal parameters (GI, PD, and CAL). At the same time, it was clarified that healthy sites in individuals with periodontal disease showed increased concentrations of biomarkers in comparison to healthy sites in subjects without periodontal disease. This could be because biomarkers were affected by the bacterial composition of the neighboring subgingival plaque [98] and the fact that the development of periodontitis was site-specific [53].

5.1.2. Microcapillary Pipetting

The time needed to collect GCF samples was related to the desired amount of GCF required and also to the condition of the sample sites (diseased or healthy). The majority of clinical studies collected GCF samples by keeping the microcapillary pipettes at the entry of the pocket for 10 minutes [22, 85]. From our experience, this duration was sufficient if we collected the GCF samples from diseased sites. However, collection of the samples from healthy subjects or healthy sites in patients with periodontitis required 30–50 minutes. This difference in collection time between healthy and diseased sites was due to the flow of GCF which was positively related to the severity of periodontal disease [113–115]. The lengthy duration needed to collect GCF when using microcapillary pipettes was considered one of the limitations of this technique, which could increase the possibility of saliva and blood contamination. It would also require more effort from the clinician and could be time-consuming for the subjects.

5.1.3. Washing Method

The results of this review showed that the washing technique of GCF collection were not common due to the technique sensitive difficulties. Also, there was a high rate of blood contamination due to the increased possibility of gingival irritation.

5.2. GCF Analytical Method

In the absence of convincing evidence and the deficiency of data from well-designed studies that focused on the techniques used in the analysis of GCF and after determining the advantages and disadvantages of each technique, it was still difficult to declare that a specific technique was better than others. This was especially so if we considered the following aspects: (a) accuracy and efficiency in biomarker detection and quantification, (b) feasibility, (c) cost, and (d) time. It was clearly shown that the majority of researchers used the ELISA technique in their clinical studies, probably due to its simplicity. It is quite important to clarify that the use of ELISA is not the most accurate technique. For example, Leppilahti et al. [73] showed that the IFMA technique is more accurate than using ELISA.

5.3. Oral Biomarkers for Periodontal Disease Analyzed from GCF Sampling

To date, an accurate diagnosis depends mainly on clinical periodontal examination, radiographic examination, and laboratory tests for microbial analyses [116] that permit a precise evaluation and analysis of bone and attachment loss levels. These findings could be supplemented by GCF analyses where, as many studies have suggested, GCF is a source of bimolecular sampling to investigate the condition of periodontal tissues [112, 117]. GCF ingredients are composed of many components that have been described as markers for periodontal disease development. These comprise host-derived enzymes, host-response modifiers, and tissue breakdown products [64].

It is known that biomarkers are objective and measurable characteristics of biological processes [118] and they can support clinical evaluation, that is, if we fully understand the normal physiology of the biological processes of periodontal disease diagnosis and progression [119]. There are many biomarkers that can be derived from different biofluids such as blood, serum, saliva, and GCF and from different sources such as microbial dental plaque biofilm, connective tissue breakdown products, inflammatory mediators, and host derivatives. For example, MMPs that exist in GCF, saliva, mouth-rinses, and peri-implant sulcular fluid (PISF) can be used to discover a novel chair-side and point-of-care analytical test, which is a nontraumatic method for the diagnosis of periodontal diseases [120, 121].

In this review we focused on GCF biomarkers because of their close proximity to periodontal tissue which minimizes the possibility of reflecting a response on other inflammatory processes in the body.

Several studies have suggested that IL-1β levels can be used as a good biomarker to differentiate between healthy and chronic periodontitis sites [12, 41, 51, 53, 98]. They can also be used to discriminate healthy subjects from patients with AgP [41, 51, 80, 99]. Owing to the slight differences in IL-1β levels between healthy and gingivitis sites [41, 51, 103], it is difficult to use them as indicators or predictors for disease initiation from healthy status to gingivitis.

Much greater levels of MMP-8 in GCF have been observed in periodontitis patients than in healthy subjects [6, 67, 88, 98, 122, 123]. This variation in MMP-8 levels can serve as an indicator for periodontal disease development. Furthermore, Leppilahti et al. [72] found that the levels of MMP-8 in GCF at baseline can predict the behavior of MMP-8 levels during the phase of maintenance.

Yakob et al. [11] however found that there were no statistical differences between healthy and diseased groups, attributing these findings to the differences in the methods used for GCF collection.

The results of this review, as also indicated in many studies, showed minimal increase in TNF-α levels from healthy to periodontally diseased sites [59, 80, 99, 103]. In other studies there was substantial elevation in TNF-α concentration from healthy to diseased sites [14, 70, 91]. Thus, TNF-α concentrations may also be used as a predictor of disease progression.

This systematic review aimed to explore the most reasonable factors that lead to variability in the findings among different studies even when using the same analytical techniques. In order to achieve this, a comparison between the mean values of two biomarkers (IL-1β and MMP-8) was conducted (Tables 7 and 8). The studies that comprised sufficient data such as sample numbers, clear analytical techniques, number or amount of GCF samples, and accurate assessment of the clinical diagnosis through the use of clinical diagnostic parameters (PD, CAL, PI, BOP, and GI) were included in this comparison. Studies that included smokers and diabetic subjects were excluded to minimize the effects on the results. For instance, clinical studies in different populations showed that smoking increased the risk of periodontitis and also that smokers had higher progression and severity of periodontal disease [124]. Tymkiw et al. [102] found that smoking inhibited the expression of many biomarkers including proinflammatory chemokines, regulators of T-cells, and natural killer cells. This inhibition resulted in a decrease in the recruitment of many proinflammatory cytokines and cells to the periodontally inflamed sites, which caused unsuccessful protection against bacterial invasion.

Furthermore, the mechanisms that explain the association between diabetes and periodontitis are not fully understood but encompass aspects of immune function, inflammation, cytokine biology, and neutrophil activity [125]. Types 1 and 2 diabetes have been related to elevated levels of inflammatory mediators [126], such as IL-1β [127] and TNF- α [128].

Table 7 shows a wide variety in the mean values of IL-1β concentrations in the studies. However, the majority of investigators used similar parameters such as size of study population which may affect mean and standard deviation, GCF collection methods (mainly paper strips), analytical techniques (standard ELISA), and clinical diagnostic parameters to categorize the study sample (mainly PD, CAL, PI, and BOP). However, we have noticed that companies manufacturing ELISA kits apply different protocols for measurements of biomarkers and the kit reagents may vary in their detection ability. Another contributing factor to this variability may be the difference in the amount of the collected GCF fluids, ranging from 1–4 paper strips collected from each subject. Such differences in GCF volumes may also cause wide variation in detection rates of biomarkers. This can be supported by the results in Table 8 which showed slight differences between the biomarker mean values, as both studies used the same ELISA kit protocol (R & D System) and an equal number of GCF samples (1 paper strip).

6. Limitations

Due to the heterogeneity of strategies used in the reviewed studies such as sampling, analytical methods, and biomarkers used, a meta-analysis of the results was not possible.

7. Conclusion

In the case of GCF collection methods, paper strips are the easiest and a more precise method. For GCF sample analysis, it is difficult to determine the most accurate method of analysis, but this review has noted that the majority of researchers depended on ELISA technique.

It can be concluded that it is better to use more than one biomarker in determining the inflammatory activity of periodontal disease. IL-1β and MMP-8 can be considered the most preferred cytokines for determining inflammatory activity in the periodontium.

The collected GCF volume and different ELISA kit manufacturing companies are the major causative factors for variation among the investigators.

In general, it is still early to depend on oral biomarkers alone in the diagnosis of periodontal disease, especially in the absence of universal methods for the collection and analysis of these biomarkers. However, it can be utilized to support the clinical parameters which are the most reliable diagnostic methods and also for monitoring periodontal disease progression.

Recommendations for Future Studies

The aim for investigating oral biomarkers is to discover the possibility of using them in the prediction, diagnosis, and monitoring of periodontal diseases or at least to be used as adjunctive to traditional periodontal examination and diagnosis. We believe that, in order to achieve this, researchers should take into consideration the following recommendations in their future studies:(1)The measurement of GCF biomarkers levels should be done by using different collection and analytical methods in order to determine the most accurate technique that can be standardized universally.(2)Comparison of GCF biomarkers levels in different ethnic groups consisting of large sample size should be considered in order to explore the effects of genetic differences on biomarkers levels and also to enable proper statistical analysis.(3)The choice of biomarkers in GCF derived studies is important. Biomarkers that are known to influence the prediction and progression of periodontal diseases should be investigated for statistical correlation to each other. Examples of biomarkers which can contribute to this are IL-1β and MMP-8 whereby Salminen et al. [129] used three salivary biomarkers together to diagnose periodontal disease.

Competing Interests

The authors have declared that there is no conflict of interests.

Authors’ Contributions

All authors contributed equally to this work.

Acknowledgments

This work was supported by the University of Malaya’s High Impact Research with Malaysian Ministry of Higher Education (HIR-MOHE) Research Grant UM.C/625/1/HIR/MOHE/SC/08 (account no. F000008-21001) under the Principal Investigator Koshy Philip and the University of Malaya, Kuala Lumpur, Malaysia, under Grant no. PG226-2014B.

References

S. C. Holt and J. L. Ebersole, “Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis,” Periodontology 2000, vol. 38, no. 1, pp. 72–122, 2005.
View at: Google Scholar
G. C. Armitage, “Periodontal diseases: diagnosis,” Annals of Periodontology/the American Academy of Periodontology, vol. 1, no. 1, article 37, 1996.
View at: Publisher Site | Google Scholar
N. Bostanci, T. İlgenli, G. Emingil et al., “Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio,” Journal of Clinical Periodontology, vol. 34, no. 5, pp. 370–376, 2007.
View at: Publisher Site | Google Scholar
R. J. Genco, “Host responses in periodontal diseases: current concepts,” Journal of Periodontology, vol. 63, no. 4, pp. 338–355, 1992.
View at: Publisher Site | Google Scholar
A. Savage, K. A. Eaton, D. R. Moles, and I. Needleman, “A systematic review of definitions of periodontitis and methods that have been used to identify this disease,” Journal of Clinical Periodontology, vol. 36, no. 6, pp. 458–467, 2009.
View at: Publisher Site | Google Scholar
P. Mäntylä, M. Stenman, D. F. Kinane et al., “Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis,” Journal of Periodontal Research, vol. 38, no. 4, pp. 436–439, 2003.
View at: Publisher Site | Google Scholar
H. Y. Chen, S. W. Cox, B. M. Eley, P. Mäntylä, H. Rönkä, and T. Sorsa, “Matrix metalloproteinase-8 levels and elastase activities in Gingival Crevicular Fluid from chronic adult periodontitis patients,” Journal of Clinical Periodontology, vol. 27, no. 5, pp. 366–369, 2000.
View at: Publisher Site | Google Scholar
L. A. Miranda, A. G. Islabão, R. G. Fischer, C. M. S. Figueredo, R. V. Oppermann, and A. Gustafsson, “Decreased interleukin-1β and elastase in the gingival crevicular fluid of individuals undergoing anti-inflammatory treatment for rheumatoid arthritis,” Journal of Periodontology, vol. 78, no. 8, pp. 1612–1619, 2007.
View at: Publisher Site | Google Scholar
N. Téllez, N. Aguilera, B. Quiñónez, E. Silva, L. E. González, and L. Hernández, “Arginine and glutamate levels in the gingival crevicular fluid from patients with chronic periodontitis,” Brazilian Dental Journal, vol. 19, no. 4, pp. 318–322, 2008.
View at: Google Scholar
B. Thaweboon, P. Laohapand, C. Amornchat et al., “Host β-globin gene fragments in crevicular fluid as a biomarker in periodontal health and disease,” Journal of Periodontal Research, vol. 45, no. 1, pp. 38–44, 2010.
View at: Publisher Site | Google Scholar
M. Yakob, J. Meurman, T. Sorsa, and B. Söder, “Treponema denticola associates with increased levels of MMP-8 and MMP-9 in gingival crevicular fluid,” Oral Diseases, vol. 19, no. 7, pp. 694–701, 2013.
View at: Publisher Site | Google Scholar
A. U. Chaudhari, G. N. Byakod, P. F. Waghmare, and V. M. Karhadkar, “Correlation of levels of interleukin-1β in gingival crevicular fluid to the clinical parameters of chronic periodontitis,” The Journal of Contemporary Dental Practice, vol. 12, no. 1, pp. 52–59, 2011.
View at: Publisher Site | Google Scholar
N. H. Gokhale, A. B. Acharya, V. S. Patil, D. J. Trivedi, S. Setty, and S. L. Thakur, “Resistin levels in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus,” Journal of Periodontology, vol. 85, no. 4, pp. 610–617, 2014.
View at: Publisher Site | Google Scholar
K. Gokul, “Estimation of the level of tumor necrosis factor- in gingival crevicular fluid and serum in periodontal health and disease: A Biochemical Study,” Indian Journal of Dental Research, vol. 23, no. 3, pp. 348–352, 2012.
View at: Publisher Site | Google Scholar
M. Gupta, R. Chaturvedi, and A. Jain, “Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease,” Cytokine, vol. 61, no. 3, pp. 892–897, 2013.
View at: Publisher Site | Google Scholar
A. K. Kumar, N. R. Reddy, M. Babu, P. M. Kumar, V. S. Reddy, and C. V. Chavan, “Estimation of prostaglandin E₂ levels in gingival crevicular fluid in periodontal health, disease and after treatment,” Contemporary Clinical Dentistry, vol. 4, no. 3, pp. 303–306, 2013.
View at: Publisher Site | Google Scholar
J. J. Kunjappu, V. B. Mathew, S. Hegde, R. Kashyap, and R. Hosadurga, “Assessment of the alkaline phosphatase level in gingival crevicular fluid, as a biomarker to evaluate the effect of scaling and root planing on chronic periodontitis: an in vivostudy,” Journal of Oral & Maxillofacial Pathology, vol. 16, no. 1, pp. 54–57, 2012.
View at: Publisher Site | Google Scholar
R. Malhotra, V. Grover, A. Kapoor, and R. Kapur, “Alkaline phosphatase as a periodontal disease marker,” Indian Journal of Dental Research, vol. 21, no. 4, pp. 531–536, 2010.
View at: Publisher Site | Google Scholar
S. T. Manojkumar, A. Pradeep, G. Garg, and A. Raju, “Gingival crevicular fluid levels of oncostatin M in periodontal conditions,” Cytokine, vol. 50, no. 3, pp. 248–252, 2010.
View at: Publisher Site | Google Scholar
S. U. Nayak, D. G. Nayak, A. S. Uppoor, and K. K. Pai, “Evaluation of cortisol levels in gingival crevicular fluid and saliva in anxious and non-anxious patients with chronic periodontitis,” Dental Research Journal, vol. 10, no. 4, p. 474, 2013.
View at: Google Scholar
S. P. Patel, A. R. Pradeep, and S. Chowdhry, “Crevicular fluid levels of plasma glutathione peroxidase (eGPx) in periodontal health and disease,” Archives of Oral Biology, vol. 54, no. 6, pp. 543–548, 2009.
View at: Publisher Site | Google Scholar
A. R. Pradeep, H. Daisy, and P. Hadge, “Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease,” Archives of Oral Biology, vol. 54, no. 5, pp. 503–509, 2009.
View at: Publisher Site | Google Scholar
A. R. Pradeep, H. Daisy, P. Hadge, G. Garg, and M. Thorat, “Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease,” Journal of Periodontology, vol. 80, no. 9, pp. 1454–1461, 2009.
View at: Publisher Site | Google Scholar
A. R. Pradeep, R. Kathariya, N. M. Raghavendra, and A. Sharma, “Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease,” Journal of Periodontology, vol. 82, no. 5, pp. 734–741, 2011.
View at: Publisher Site | Google Scholar
A. R. Pradeep, M. S. Kumar, M. V. Ramachandraprasad, and C. Shikha, “Gingival crevicular fluid levels of neopterin in healthy subjects and in patients with different periodontal diseases,” Journal of Periodontology, vol. 78, no. 10, pp. 1962–1967, 2007.
View at: Publisher Site | Google Scholar
A. Pradeep, R. S. Manjunath, and R. Kathariya, “Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels,” Journal of Investigative and Clinical Dentistry, vol. 1, no. 2, pp. 133–138, 2010.
View at: Publisher Site | Google Scholar
A. R. Pradeep, S. G. Manjunath, P. P. Swati, C. Shikha, and P. B. Sujatha, “Gingival crevicular fluid levels of leukotriene B4 in periodontal health and disease,” Journal of Periodontology, vol. 78, no. 12, pp. 2325–2330, 2007.
View at: Publisher Site | Google Scholar
A. R. Pradeep, D. V. Prapulla, A. Sharma, and P. B. Sujatha, “Gingival crevicular fluid and serum vascular endothelial growth factor: their relationship in periodontal health, disease and after treatment,” Cytokine, vol. 54, no. 2, pp. 200–204, 2011.
View at: Publisher Site | Google Scholar
A. R. Pradeep, N. M. Raghavendra, A. Sharma et al., “Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus,” Journal of Periodontology, vol. 83, no. 5, pp. 629–634, 2012.
View at: Publisher Site | Google Scholar
A. R. Pradeep, P. Hadge, S. Chowdhry, S. Patel, and D. Happy, “Exploring the role of Th1 cytokines: interleukin-17 and interleukin-18 in periodontal health and disease,” Journal of Oral Science, vol. 51, no. 2, pp. 261–266, 2009.
View at: Publisher Site | Google Scholar
D. V. Prapulla, P. B. Sujatha, and A. R. Pradeep, “Gingival crevicular fluid VEGF levels in periodontal health and disease,” Journal of Periodontology, vol. 78, no. 9, pp. 1783–1787, 2007.
View at: Publisher Site | Google Scholar
N. M. Raghavendra, A. R. Pradeep, R. Kathariya, A. Sharma, N. S. Rao, and S. B. Naik, “Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease,” Disease Markers, vol. 32, no. 6, pp. 383–388, 2012.
View at: Publisher Site | Google Scholar
S. Sanikop, S. Patil, and P. Agrawal, “Gingival crevicular fluid alkaline phosphatase as a potential diagnostic marker of periodontal disease,” Journal of Indian Society of Periodontology, vol. 16, no. 4, pp. 513–518, 2012.
View at: Publisher Site | Google Scholar
A. Sharma, A. R. Pradeep, N. M. Raghavendra, P. Arjun, and R. Kathariya, “Gingival crevicular fluid and serum cystatin c levels in periodontal health and disease,” Disease Markers, vol. 32, no. 2, pp. 101–107, 2012.
View at: Publisher Site | Google Scholar
C. G. D. Sharma and A. R. Pradeep, “Gingival crevicular fluid osteopontin levels in periodontal health and disease,” Journal of Periodontology, vol. 77, no. 10, pp. 1674–1680, 2006.
View at: Publisher Site | Google Scholar
B. Alfant, L. M. Shaddox, J. Tobler, I. Magnusson, I. Aukhil, and C. Walker, “Matrix metalloproteinase levels in children with aggressive periodontitis,” Journal of Periodontology, vol. 79, no. 5, pp. 819–826, 2008.
View at: Publisher Site | Google Scholar
E. Andersen, I. M. Dessaix, T. Perneger, and A. Mombelli, “Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment,” Journal of Periodontal Research, vol. 45, no. 4, pp. 458–463, 2010.
View at: Publisher Site | Google Scholar
E. Baltacıoğlu, F. A. Akalin, A. Alver, O. Değer, and E. Karabulut, “Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis,” Archives of Oral Biology, vol. 53, no. 8, pp. 716–722, 2008.
View at: Publisher Site | Google Scholar
E. Baltacıoğlu, M. A. Kehribar, P. Yuva et al., “Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis,” Journal of Periodontology, vol. 85, no. 2, pp. 317–326, 2014.
View at: Publisher Site | Google Scholar
S. Becerik, B. Afacan, V. Ö. Öztürk, H. Atmaca, and G. Emingil, “Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases,” Disease Markers, vol. 31, no. 6, pp. 343–352, 2011.
View at: Publisher Site | Google Scholar
S. Becerik, V. Ö. Öztürk, H. Atmaca, G. Atilla, and G. Emingil, “Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases,” Journal of Periodontology, vol. 83, no. 10, pp. 1304–1313, 2012.
View at: Publisher Site | Google Scholar
G. N. Belibasakis, V.-Ö. Öztürk, G. Emingil, and N. Bostanci, “Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in gingival crevicular fluid: association with clinical and microbiologic parameters,” Journal of Periodontology, vol. 85, no. 1, pp. 204–210, 2014.
View at: Publisher Site | Google Scholar
B. Bıyıkoğlu, N. Buduneli, L. Kardeşler, K. Aksu, M. Pitkala, and T. Sorsa, “Gingival crevicular fluid MMP-8 and-13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease,” Journal of Periodontology, vol. 80, no. 8, pp. 1307–1314, 2009.
View at: Publisher Site | Google Scholar
N. Bostanci, B. Saygan, G. Emingil, G. Atilla, and G. N. Belibasakis, “Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid,” Journal of Clinical Periodontology, vol. 38, no. 5, pp. 428–433, 2011.
View at: Publisher Site | Google Scholar
N. Buduneli, Ö. Özçaka, and A. Nalbantsoy, “Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis,” Journal of Periodontology, vol. 83, no. 3, pp. 362–368, 2012.
View at: Publisher Site | Google Scholar
P. Bullon, B. Goberna, J. M. Guerrero, J. J. Segura, R. Perez-Cano, and A. Martinez-Sahuquillo, “Serum, saliva, and gingival crevicular fluid osteocalcin: Their relation to periodontal status and bone mineral density in postmenopausal women,” Journal of Periodontology, vol. 76, no. 4, pp. 513–519, 2005.
View at: Publisher Site | Google Scholar
F. O. B. Correa, D. Gonçalves, C. M. S. Figueredo, A. Gustafsson, and S. R. P. Orrico, “The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1β and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis,” Journal of Periodontology, vol. 79, no. 11, pp. 2143–2150, 2008.
View at: Publisher Site | Google Scholar
R. R. De Oliveira, H. O. Schwartz-Filho, A. B. Novaes Jr. et al., “Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: cytokine profile in gingival crevicular fluid, preliminary results,” Journal of Periodontology, vol. 80, no. 1, pp. 98–105, 2009.
View at: Publisher Site | Google Scholar
G. Emingil, A. Gürkan, G. Atilla, and A. Kantarci, “Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid,” Journal of Periodontology, vol. 82, no. 3, pp. 452–461, 2011.
View at: Publisher Site | Google Scholar
G. Emingil, B. Han, G. Özdemir et al., “Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis,” Journal of Periodontal Research, vol. 47, no. 6, pp. 729–739, 2012.
View at: Publisher Site | Google Scholar
A. S. Ertugrul, H. Sahin, A. Dikilitas, N. Alpaslan, and A. Bozoglan, “Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis,” Journal of Periodontal Research, vol. 48, no. 1, pp. 44–51, 2013.
View at: Publisher Site | Google Scholar
T. Fiorini, C. Susin, J. M. Da Rocha et al., “Effect of nonsurgical periodontal therapy on serum and gingival crevicular fluid cytokine levels during pregnancy and postpartum,” Journal of Periodontal Research, vol. 48, no. 1, pp. 126–133, 2013.
View at: Publisher Site | Google Scholar
Y. Fujita, H. Ito, S. Sekino, and Y. Numabe, “Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis,” Odontology, vol. 100, no. 2, pp. 215–221, 2012.
View at: Publisher Site | Google Scholar
N. Ghallab, E. Hamdy, and O. Shaker, “Malondialdehyde, superoxide dismutase and melatonin levels in gingival crevicular fluid of aggressive and chronic periodontitis patients,” Australian Dental Journal, vol. 61, no. 1, pp. 53–61, 2016.
View at: Publisher Site | Google Scholar
P. F. Gonçalves, H. Huang, S. McAninley et al., “Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis,” Journal of Periodontology, vol. 84, no. 12, pp. 1801–1808, 2013.
View at: Publisher Site | Google Scholar
D.-H. Han, H.-S. Shin, D. Paek, and H.-D. Kim, “Gingival crevicular fluid levels of matrix metalloproteinases cross-sectionally related to periodontitis and metabolic syndrome in community Koreans,” Journal of Clinical Periodontology, vol. 39, no. 12, pp. 1125–1131, 2012.
View at: Publisher Site | Google Scholar
M. Hernandez, M. A. Valenzuela, C. Lopez-Otin et al., “Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity,” Journal of Periodontology, vol. 77, no. 11, pp. 1863–1870, 2006.
View at: Publisher Site | Google Scholar
G. S. Himani, M. L. V. Prabhuji, and B. V. Karthikeyan, “Gingival crevicular fluid and interleukin-23 concentration in systemically healthy subjects: their relationship in periodontal health and disease,” Journal of Periodontal Research, vol. 49, no. 2, pp. 237–245, 2014.
View at: Publisher Site | Google Scholar
I. Ikezawa, H. Tai, Y. Shimada, Y. Komatsu, J. C. Galicia, and H. Yoshie, “Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis,” Journal of Clinical Periodontology, vol. 32, no. 10, pp. 1047–1054, 2005.
View at: Publisher Site | Google Scholar
N. Kalra, A. R. Pradeep, N. Priyanka, and M. Kumari, “Association of stem cell factor and high-sensitivity C reactive protein concentrations in crevicular fluid and serum in patients with chronic periodontitis with and without type 2 diabetes,” Journal of Oral Science, vol. 55, no. 1, pp. 57–62, 2013.
View at: Publisher Site | Google Scholar
D. Kaner, J.-P. Bernimoulin, T. Dietrich, B.-M. Kleber, and A. Friedmann, “Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis,” Journal of Periodontal Research, vol. 46, no. 4, pp. 417–426, 2011.
View at: Publisher Site | Google Scholar
D. Kaner, J.-P. Bernimoulin, B.-M. Kleber, W. R. Heizmann, and A. Friedmann, “Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis,” Journal of Periodontal Research, vol. 41, no. 2, pp. 132–139, 2006.
View at: Publisher Site | Google Scholar
G. C. Keles, B. O. Cetinkaya, I. Isildak, H. Koprulu, and G. Acikgoz, “Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy,” Journal of Periodontal Research, vol. 41, no. 6, pp. 513–518, 2006.
View at: Publisher Site | Google Scholar
S. Khongkhunthian, P. Kongtawelert, S. Ongchai et al., “Comparisons between two biochemical markers in evaluating periodontal disease severity: A Cross-Sectional Study,” BMC Oral Health, vol. 14, no. 1, article 107, 2014.
View at: Publisher Site | Google Scholar
S. Khongkhunthian, N. Srimueang, S. Krisanaprakornkit, K. Pattanaporn, S. Ong-Chai, and P. Kongtawelert, “Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis,” Journal of Clinical Periodontology, vol. 35, no. 10, pp. 871–876, 2008.
View at: Publisher Site | Google Scholar
J. S. Kinney, T. Morelli, M. Oh et al., “Crevicular fluid biomarkers and periodontal disease progression,” Journal of Clinical Periodontology, vol. 41, no. 2, pp. 113–120, 2014.
View at: Publisher Site | Google Scholar
Ł. Konopka, A. Pietrzak, and E. Brzezińska-Błaszczyk, “Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients,” Journal of Periodontal Research, vol. 47, no. 6, pp. 681–688, 2012.
View at: Publisher Site | Google Scholar
M. Kraft-Neumärker, K. Lorenz, R. Koch et al., “Full-mouth profile of active MMP-8 in periodontitis patients,” Journal of Periodontal Research, vol. 47, no. 1, pp. 121–128, 2012.
View at: Publisher Site | Google Scholar
M. Kumari, A. Pradeep, N. Priyanka, N. Kalra, and S. B. Naik, “Crevicular and serum levels of monocyte chemoattractant protein-4 and high-sensitivity C-reactive protein in periodontal health and disease,” Archives of Oral Biology, vol. 59, no. 6, pp. 645–653, 2014.
View at: Publisher Site | Google Scholar
B. Kurtiş, G. Tüter, M. Serdar et al., “Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis,” Journal of Periodontology, vol. 76, no. 11, pp. 1849–1855, 2005.
View at: Publisher Site | Google Scholar
B. Kurtiş, G. Tüter, M. Serdar, S. Pinar, I. Demirel, and U. Toyman, “Gingival crevicular fluid prostaglandin E2 and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen,” Journal of Periodontology, vol. 78, no. 1, pp. 104–111, 2007.
View at: Publisher Site | Google Scholar
J. M. Leppilahti, M. A. Kallio, T. Tervahartiala, T. Sorsa, and P. Mäntylä, “Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis,” Journal of Periodontology, vol. 85, no. 2, pp. 250–260, 2014.
View at: Publisher Site | Google Scholar
J. M. Leppilahti, P. A. Hernández-Ríos, J. A. Gamonal et al., “Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis,” Journal of Clinical Periodontology, vol. 41, no. 4, pp. 348–356, 2014.
View at: Publisher Site | Google Scholar
K. Liu, H. Meng, R. Lu et al., “Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D3 and Interleukin-1β in patients with aggressive periodontitis,” Journal of Periodontology, vol. 81, no. 2, pp. 260–266, 2010.
View at: Publisher Site | Google Scholar
E. E. Machtei and M. N. Younis, “The use of 2 antibiotic regimens in aggressive periodontitis: comparison of changes in clinical parameters and gingival crevicular fluid biomarkers,” Quintessence International, vol. 39, no. 10, pp. 811–819, 2008.
View at: Google Scholar
A. Makeudom, S. Kulpawaropas, P. Montreekachon et al., “Positive correlations between hCAP18/LL-37 and chondroitin sulphate levels in chronic periodontitis,” Journal of Clinical Periodontology, vol. 41, no. 3, pp. 252–261, 2014.
View at: Publisher Site | Google Scholar
P. Mäntylä, M. Stenman, D. Kinane et al., “Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test,” Journal of Periodontal Research, vol. 41, no. 6, pp. 503–512, 2006.
View at: Publisher Site | Google Scholar
A. M. Marcaccini, C. A. Meschiari, L. R. Zuardi et al., “Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy,” Journal of Clinical Periodontology, vol. 37, no. 2, pp. 180–190, 2010.
View at: Publisher Site | Google Scholar
M. T. C. McCrudden, D. F. Orr, Y. Yu et al., “LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid,” Journal of Clinical Periodontology, vol. 40, no. 10, pp. 933–941, 2013.
View at: Publisher Site | Google Scholar
A. P. De Lima Oliveira, M. De Faveri, L. C. Gursky et al., “Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects,” Journal of Clinical Periodontology, vol. 39, no. 3, pp. 295–302, 2012.
View at: Publisher Site | Google Scholar
F. Ö. Dede, F. O. Özden, and B. Avci, “8-hydroxy-deoxyguanosine levels in gingival crevicular fluid and saliva in patients with chronic periodontitis after initial periodontal treatment,” Journal of Periodontology, vol. 84, no. 6, pp. 821–828, 2013.
View at: Publisher Site | Google Scholar
E. Papathanasiou, F. Teles, T. Griffin et al., “Gingival crevicular fluid levels of interferon-γ, but not interleukin-4 or -33 or thymic stromal lymphopoietin, are increased in inflamed sites in patients with periodontal disease,” Journal of Periodontal Research, vol. 49, no. 1, pp. 55–61, 2014.
View at: Publisher Site | Google Scholar
G. Perinetti, M. Paolantonio, B. Femminella, E. Serra, and G. Spoto, “Gingival crevicular fluid alkaline phosphatase activity reflects periodontal healing/recurrent inflammation phases in chronic periodontitis patients,” Journal of Periodontology, vol. 79, no. 7, pp. 1200–1207, 2008.
View at: Publisher Site | Google Scholar
R. Pourabbas, A. Kashefimehr, N. Rahmanpour et al., “Effects of photodynamic therapy on clinical and gingival crevicular fluid inflammatory biomarkers in chronic periodontitis: a split-mouth randomized clinical trial,” Journal of Periodontology, vol. 85, no. 9, pp. 1222–1229, 2014.
View at: Publisher Site | Google Scholar
A. R. Pradeep, N. M. Raghavendra, M. V. R. Prasad, R. Kathariya, S. P. Patel, and A. Sharma, “Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease,” Journal of Periodontology, vol. 82, no. 9, pp. 1314–1319, 2011.
View at: Publisher Site | Google Scholar
A. R. Pradeep, N. S. Rao, P. Bajaj, and E. Agarwal, “8-Isoprostane: a lipid peroxidation product in gingival crevicular fluid in healthy, gingivitis and chronic periodontitis subjects,” Archives of Oral Biology, vol. 58, no. 5, pp. 500–504, 2013.
View at: Publisher Site | Google Scholar
N. Priyanka, M. Kumari, N. Kalra, P. Arjun, S. B. Naik, and A. R. Pradeep, “Crevicular fluid and serum concentrations of progranulin and high sensitivity CRP in chronic periodontitis and type 2 diabetes,” Disease Markers, vol. 35, no. 5, pp. 389–394, 2013.
View at: Publisher Site | Google Scholar
B. Rai, J. Kaur, R. Jain, and S. C. Anand, “Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis,” The Saudi Dental Journal, vol. 22, no. 3, pp. 129–131, 2010.
View at: Publisher Site | Google Scholar
B. Rai, S. Kharb, R. Jain, and S. C. Anand, “Biomarkers of periodontitis in oral fluids,” Journal of Oral Science, vol. 50, no. 1, pp. 53–56, 2008.
View at: Publisher Site | Google Scholar
R. A. Reinhardt, J. A. Stoner, L. M. Golub et al., “Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis,” Journal of Periodontology, vol. 81, no. 2, pp. 251–259, 2010.
View at: Publisher Site | Google Scholar
C. Reis, A. V. Da Costa, J. T. Guimarães et al., “Clinical improvement following therapy for periodontitis: association with a decrease in IL-1 and IL-6,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 323–327, 2014.
View at: Publisher Site | Google Scholar
W. Rosalem, B. Rescala, R. P. Teles, R. G. Fischer, A. Gustafsson, and C. M. Figueredo, “Effect of non-surgical treatment on chronic and aggressive periodontitis: clinical, immunologic, and microbiologic findings,” Journal of Periodontology, vol. 82, no. 7, pp. 979–989, 2011.
View at: Publisher Site | Google Scholar
G. E. Salvi, L. M. Franco, T. M. Braun et al., “Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: A Proof-of-Concept Study,” Journal of Clinical Periodontology, vol. 37, no. 1, pp. 9–16, 2010.
View at: Publisher Site | Google Scholar
V. R. Santos, F. V. Ribeiro, J. A. Lima et al., “Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors,” Journal of Periodontal Research, vol. 47, no. 1, pp. 45–54, 2012.
View at: Publisher Site | Google Scholar
F. Sarlati, M. Sattari, S. Razzaghi, and M. Nasiri, “Receptor activator of nuclear factor κ B ligand and osteoprotegerin levels in gingival crevicular fluid,” Dental Research Journal, vol. 9, no. 6, pp. 752–757, 2012.
View at: Google Scholar
T. Sorsa, M. Hernández, J. Leppilahti, S. Munjal, L. Netuschil, and P. Mäntylä, “Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods,” Oral Diseases, vol. 16, no. 1, pp. 39–45, 2010.
View at: Publisher Site | Google Scholar
T. H. Tang, T. R. Fitzsimmons, and P. M. Bartold, “Effect of smoking on concentrations of receptor activator of nuclear factor κ B ligand and osteoprotegerin in human gingival crevicular fluid,” Journal of Clinical Periodontology, vol. 36, no. 9, pp. 713–718, 2009.
View at: Publisher Site | Google Scholar
R. Teles, D. Sakellari, F. Teles et al., “Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota,” Journal of Periodontology, vol. 81, no. 1, pp. 89–98, 2010.
View at: Publisher Site | Google Scholar
R. P. Teles, L. C. Gursky, M. Faveri et al., “Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis,” Journal of Clinical Periodontology, vol. 37, no. 4, pp. 313–323, 2010.
View at: Publisher Site | Google Scholar
H. Toker, A. Akpınar, H. Aydın, and O. Poyraz, “Influence of smoking on interleukin-1beta level, oxidant status and antioxidant status in gingival crevicular fluid from chronic periodontitis patients before and after periodontal treatment,” Journal of Periodontal Research, vol. 47, no. 5, pp. 572–577, 2012.
View at: Publisher Site | Google Scholar
G. Tüter, B. Kurtis, and M. Serdar, “Evaluation of gingival crevicular fluid and serum levels of high-sensitivity C-reactive protein in chronic periodontitis patients with or without coronary artery disease,” Journal of Periodontology, vol. 78, no. 12, pp. 2319–2324, 2007.
View at: Publisher Site | Google Scholar
K. D. Tymkiw, D. H. Thunell, G. K. Johnson et al., “Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis,” Journal of Clinical Periodontology, vol. 38, no. 3, pp. 219–228, 2011.
View at: Publisher Site | Google Scholar
A. E. Ülker, Ö. Tulunoglu, N. Özmeric, M. Can, and S. Demirtas, “The evaluation of cystatin C, IL-Iβ, and TNF-α levels in total saliva and gingival crevicular fluid from 11- to 16-year-old children,” Journal of Periodontology, vol. 79, no. 5, pp. 854–860, 2008.
View at: Publisher Site | Google Scholar
F. V. Ribeiro, A. C. De Mendoncxa, V. R. Santos, M. F. Bastos, L. C. Figueiredo, and P. M. Duarte, “Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis,” Journal of Periodontology, vol. 82, no. 8, pp. 1187–1196, 2011.
View at: Publisher Site | Google Scholar
N. Buduneli and D. F. Kinane, “Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis,” Journal of Clinical Periodontology, vol. 38, no. 11, pp. 85–105, 2011.
View at: Publisher Site | Google Scholar
J. M. Leppilahti, T. Sorsa, M. A. Kallio et al., “The utility of gingival crevicular fluid matrix metalloproteinase-8 response patterns in prediction of site-level clinical treatment outcome,” Journal of Periodontology, vol. 86, no. 6, pp. 777–787, 2015.
View at: Publisher Site | Google Scholar
A. M. Heikkinen, S. O. Nwhator, N. Rathnayake, P. Mäntylä, P. Vatanen, and T. Sorsa, “Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents,” Journal of Periodontology, vol. 87, no. 1, pp. 36–40, 2016.
View at: Publisher Site | Google Scholar
J. I. Salonen and K. U. Paunio, “An intracrevicular washing method for collection of crevicular contents,” Scandinavian Journal of Dental Research, vol. 99, no. 5, pp. 406–412, 1991.
View at: Google Scholar
G. S. Griffiths, “Formation, collection and significance of gingival crevice fluid,” Periodontology 2000, vol. 31, pp. 32–42, 2003.
View at: Publisher Site | Google Scholar
A. Guentsch, M. Kramesberger, A. Sroka, W. Pfister, J. Potempa, and S. Eick, “Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis,” Journal of Periodontology, vol. 82, no. 7, pp. 1051–1060, 2011.
View at: Publisher Site | Google Scholar
Y. Shimada, K. Tabeta, N. Sugita, and H. Yoshie, “Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay,” Archives of Oral Biology, vol. 58, no. 6, pp. 724–730, 2013.
View at: Publisher Site | Google Scholar
I. Bakri, C. W. I. Douglas, and A. Rawlinson, “The effects of stress on periodontal treatment: a longitudinal investigation using clinical and biological markers,” Journal of Clinical Periodontology, vol. 40, no. 10, pp. 955–961, 2013.
View at: Publisher Site | Google Scholar
V. Booth, S. Young, A. Cruchley, N. S. Taichman, and E. Paleolog, “Vascular endothelial growth factor in human periodontal disease,” Journal of Periodontal Research, vol. 33, no. 8, pp. 491–499, 1998.
View at: Google Scholar
L. Jin, C. Yu, and E. F. Corbet, “Granulocyte elastase activity in static and flow gingival crevicular fluid,” Journal of Periodontal Research, vol. 38, no. 3, pp. 303–310, 2003.
View at: Publisher Site | Google Scholar
Q. T. Smith, G. S. Au, P. L. Freese, J. B. Osborn, and J. L. Stoltenberg, “Five parameters of gingival crevicular fluid from eight surfaces in periodontal health and disease,” Journal of Periodontal Research, vol. 27, no. 5, pp. 466–475, 1992.
View at: Publisher Site | Google Scholar
B. L. Pihlstrom, “Periodontal risk assessment, diagnosis and treatment planning,” Periodontology 2000, vol. 25, no. 1, pp. 37–58, 2001.
View at: Publisher Site | Google Scholar
L. Luo, P. Xie, P. Gong, X.-H. Tang, Y. Ding, and L.-X. Deng, “Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis,” Archives of Oral Biology, vol. 56, no. 10, pp. 1106–1111, 2011.
View at: Publisher Site | Google Scholar
W. A. Colburn, V. G. DeGruttola, D. L. DeMets et al., “Biomarkers and surrogate endpoints: preferred definitions and conceptual framework,” Clinical Pharmacology & Therapeutics, vol. 69, no. 3, pp. 89–95, 2001.
View at: Publisher Site | Google Scholar
K. Strimbu and J. A. Tavel, “What are biomarkers?” Current Opinion in HIV and AIDS, vol. 5, no. 6, pp. 463–466, 2010.
View at: Publisher Site | Google Scholar
T. Sorsa, L. Tjäderhane, Y. T. Konttinen et al., “Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation,” Annals of Medicine, vol. 38, no. 5, pp. 306–321, 2006.
View at: Publisher Site | Google Scholar
T. Sorsa, U. K. Gursoy, S. Nwhator et al., “Analysis of matrix metalloproteinases, especially MMP-8, in gingival crevicular fluid, mouthrinse and saliva for monitoring periodontal diseases,” Periodontology 2000, vol. 70, no. 1, pp. 142–163, 2016.
View at: Publisher Site | Google Scholar
D. F. Kinane, I. B. Darby, S. Said et al., “Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance,” Journal of Periodontal Research, vol. 38, no. 4, pp. 400–404, 2003.
View at: Publisher Site | Google Scholar
C. M. S. Figueredo, A. Areas, L. A. Miranda, R. G. Fischer, and A. Gustafsson, “The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients,” Journal of Clinical Periodontology, vol. 31, no. 8, pp. 615–619, 2004.
View at: Publisher Site | Google Scholar
F. H. Nociti, M. Z. Casati, and P. M. Duarte, “Current perspective of the impact of smoking on the progression and treatment of periodontitis,” Periodontology 2000, vol. 67, no. 1, pp. 187–210, 2015.
View at: Publisher Site | Google Scholar
J. J. Taylor, P. M. Preshaw, and E. Lalla, “A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes,” Journal of Clinical Periodontology, vol. 40, supplement 14, pp. S113–S134, 2013.
View at: Publisher Site | Google Scholar
P. Dandona, A. Aljada, and A. Bandyopadhyay, “Inflammation: the link between insulin resistance, obesity and diabetes,” Trends in Immunology, vol. 25, no. 1, pp. 4–7, 2004.
View at: Publisher Site | Google Scholar
S. P. Engebretson, J. Hey-Hadavi, F. J. Ehrhardt et al., “Gingival crevicular fluid levels of interleukin-1β and glycemic control in patients with chronic periodontitis and type 2 diabetes,” Journal of Periodontology, vol. 75, no. 9, pp. 1203–1208, 2004.
View at: Publisher Site | Google Scholar
G. E. Salvi, J. G. Collins, B. Yalda, R. R. Arnold, N. P. Lang, and S. Offenbacher, “Monocytic TNFα secretion patterns in IDDM patients with periodontal diseases,” Journal of Clinical Periodontology, vol. 24, no. 1, pp. 8–16, 1997.
View at: Publisher Site | Google Scholar
A. Salminen, U. K. Gursoy, S. Paju et al., “Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis,” Journal of Clinical Periodontology, vol. 41, no. 5, pp. 442–450, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Zeyad Nazar Majeed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

8806

Downloads

2895

Citations